Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEB4 days ago · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for the companies’ Omicron KP.2-adapted monovalent COVID-19 vaccine (COMIRNATY ® KP.2) for active ...
Pfizer Receives Positive CHMP Opinion for its Treatment for …
WEB4 days ago · A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as ...
What You Need to Know About a Promising Vaccine Candidate that ... - Pfizer
WEBIn 2020, Pfizer announced a collaboration with Valneva, a European company specializing in vaccines, to codevelop and commercialize a vaccine candidate against Lyme disease. 16 The investigational product, VLA15, is a multivalent protein subunit vaccine that targets the outer surface protein A (OspA) expressed by the Borrelia bacteria when it ...
Pfizer Is Rising Past Covid-19 - Yahoo Finance
WEB1 day ago · Pfizer's pandemic-fueled revenue surge, largely driven by Covid-19 products like Comirnaty, has now become a challenge as vaccine revenues sharply decline. In the second quarter, Comirnaty sales ...
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
WEBAug 23, 2021 · Full federal approval for the Pfizer-BioNTech coronavirus vaccine for those 16 and older is opening the way for institutions like the military, corporate employers, hospitals and school...
Pfizer rolls out another cost-cutting program, sets $1.5 billion …
WEBMay 22, 2024 · U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it announced last...
Pfizer’s gene therapy for rare genetic bleeding disorder ... - CNBC
WEBJul 24, 2024 · Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The treatment for ...
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
Newsroom - Pfizer
WEB4 days ago · Updates and Statements. Pfizer Receives Positive CHMP Opinion for its Treatment for Adults and Adolescents with Hemophilia A and B. Pfizer Statement on Publication of ELIQUIS® Maximum Fair Price. View All Updates and Statements.
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEB4 days ago · A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q ...
- Some results have been removed
Skip to content